$226 - ABBV | ABBVIE INC.

ABBVIE INC. (ABBV)

ABBVIE INC.

XNYS:ABBV

226

-0.73%

Ask

$232.50 - 100.00

Bid

$225.51 - 42.00

Low

$225.51

High

$228.09

Open

$227.23

Prev Close

$227.66

52W High

244.81

52W Low

164.39

Volume

2655189

Avg Vol (3m)

6257387.3

Float

1765736336.6

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 12/10/2012

Primary Exchange: XNYS

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Phone: (847) 932-7900

Address: 1 North Waukegan Road

City: North Chicago

State: IL

Postal Code: 60064

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

55,000

P/E (TTM)

171.810156

P/B (TTM)

-152.318900

EPS

1.86

Div / Yield

2.880984

Round Lot

100

Composit FIGI

BBG0025Y4RY4

Share Class FIGI

BBG0025Y4RZ3

Share Class Shares Outstanding

1.77B

Weighted Shares Outstanding

1.77B

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion